Brentwood-based communications firm Jarrard Inc. has added a health technology practice. The practice will focus on helping health care companies navigate the regulatory landscape surrounding artificial intelligence and integrate health technology into their existing operations, according to a press release.
Alex Hunter
Courtesy of Jarrard
“We are intentionally expanding our work within the health care ecosystem to include the innovative tech companies that will help our country make a quantum leap to improve healthcare costs, accessibility and outcomes – for everyone,” said Jarrard Co-founder and President Anne Hancock Toomey.
The company has tapped Alex Hunter to lead the practice. Hunter most recently worked as co-founder of the Bulleit Group, which had a number of high-profile clients including Google, Microsoft and Bridgewater, according to the release.
Jarrard, founded in 2006, has expanded its employee roster by 10 percent this year, growing to 83 individuals in 20 states.
Brentwood Capital lands health care investment lead
Investment bank Brentwood Capital Advisors announced Wednesday that industry veteran Burk Lindsey will lead the firm’s health care services advisory business.
He will focus on post-acute care, behavioral health and retail health, according to a press release. Lindsey was most recently senior managing director in the health care investment banking at Raymond James, having spent 23 years at the company. He has advised 150 transactions with more than $10 billion in value in his tenure, according to the release.
“Burk is among the most respected health care bankers in our industry, and we are excited to welcome him to our growing team,” said L.A. Galyon, managing partner at Brentwood Capital Advisors. “His expertise, leadership, reputation, and track record of success align perfectly with our firm.”
Clover Health thrives in second quarter
Clover Health increased its guidance for 2024 following the release of its second-quarter earnings report on Monday.
The Cool Springs-based Medicare Advantage insurer anticipates generating $1.35 billion to $1.375 billion in revenue this year, which it increased from the $1.30 billion $1.35 billion first-quarter estimate.
The company saw insurance revenue grow during the second quarter by 11 percent year-over-year to $349.9 million, which Clover credits to strong member retention.
Clover CEO Andrew Toy said the company’s use of technology sets it apart from competitors.
“Through our Clover Assistant technology and integrated care management platform, we aim to empower physicians to improve clinical outcomes and lower the total cost of care for people with chronic diseases,” Toy said in a press release. “This allows us to partner with a much wider range of physicians than other plans. Our performance validates this key point of differentiation, and I believe positions us to thrive in the future of the Medicare Advantage market.”
Clover Health (ticker: CLOV) shares closed priced at $1.83 on Thursday afternoon (up 9.9 percent) after having increased to $2.00 on Tuesday.
.tmb-1200v.jpg?Culture=en&sfvrsn=6e040c36_6 "December edition of the WHO Bulletin")
